2Wang W,Ma L,Zhang Y,et al.The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients:rationale,design and baseline characteristics[].Journal of Human Hypertension.2011
3Liu L,Wang JG,Gong L,et al.Comparison of active treatment and placebo in older chinese patients with isolated systolic hypertension.Systolic Hypertension in China (Syst-China) Collaborative Group[].Journal of Hypertension.1998
4Progress Collaborative Group.Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack[].The Lancet.2001
5Neutel J M,Saunders E,,Bakris GL,et al.The efficacy and safety of low and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic bloodpressure on monotherapy:the I NCLUSI VE trial[].J Clin Hypertens(Greenwich).2005
3Liu LS, Zhang YQ, Liu GZ, etal. For the FEVER Study Group. The felodipine event reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients [J]. J Hypertens,2005,23(12) :2157-2172.
4Samuelsson OG, Wilhelmsen LW, Pennert KM, et al. The J- shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the primary prevention trial in gothenburg, sweden[J]. J Hypertens, 1990,8(6) : 547- 555.
5Yusuf S, Diener HC, Sacco RL, et al. For PROFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events[J]. N Engl J Med, 2008,359 (12) : 1225-1237.
6Lawes CM, Rodgers A, Bennett DA, et al. For asia pacific cohort studies collaboration. Blood pressure and cardiovascular diseases in the Asia-Pacific region[J]. J Hypertens, 2003,21 (4) : 707-716.
7Lewington S, Clarke R, Qizilbash N, et al. For prospective studies collaboration. Age-specific relevanee of usual blood pressure to vascular mortality., a meta-analysis of individual data for one million adults in 61 prospective studies[J]. Lancet, 2002,360(9349): 1903-1913.
8Arima H, Chalmers J, Woodward M, et al. For the PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial [J]. J Hypertens,2006,24(6) : 1201-1208.
9Arima H, Anderson C, Omae T. For the PROGRESS Collaborative Group. Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial[J]. J Hypertens, 2010,28 (2) :395-400.
10Zanchetti A, Mancia G, Black HR, et al. Facts and fallacies of blood pressure control in recent trials:implications in the management of patients with hypertension[J]. J. Hypertens, 2009,27 (4) : 673-679.
